• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

概念化模型:ISPOR-SMDM 建模良好研究实践工作组 2 的报告。

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.

机构信息

Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, USA, and Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA (MR)

Institute for Health and Department of Economics, Rutgers University, New Brunswick, NJ, USA (LBR)

出版信息

Med Decis Making. 2012 Sep-Oct;32(5):678-89. doi: 10.1177/0272989X12454941.

DOI:10.1177/0272989X12454941
PMID:22990083
Abstract

The appropriate development of a model begins with understanding the problem that is being represented. The aim of this article is to provide a series of consensus-based best practices regarding the process of model conceptualization. For the purpose of this series of papers, the authors consider the development of models whose purpose is to inform medical decisions and health-related resource allocation questions. They specifically divide the conceptualization process into two distinct components: the conceptualization of the problem, which converts knowledge of the health care process or decision into a representation of the problem, followed by the conceptualization of the model itself, which matches the attributes and characteristics of a particular modeling type to the needs of the problem being represented. Recommendations are made regarding the structure of the modeling team, agreement on the statement of the problem, the structure, perspective and target population of the model, and the interventions and outcomes represented. Best practices relating to the specific characteristics of model structure, and which characteristics of the problem might be most easily represented in a specific modeling method, are presented. Each section contains a number of recommendations that were iterated among the authors, as well as the wider modeling taskforce, jointly set up by the International Society for Pharmacoeconomics and Outcomes Research and the Society for Medical Decision Making.

摘要

模型的恰当开发始于对所代表问题的理解。本文旨在提供一系列基于共识的最佳实践,涉及模型概念化的过程。在本系列论文中,作者考虑开发旨在为医疗决策和与健康相关的资源分配问题提供信息的模型。他们特别将概念化过程分为两个不同的组件:问题的概念化,即将对医疗保健过程或决策的知识转化为问题的表示,然后是模型本身的概念化,即将特定建模类型的属性和特征与所代表问题的需求相匹配。就建模团队的结构、对问题的陈述、模型的结构、视角和目标人群以及所代表的干预措施和结果达成一致意见提出建议。介绍了与模型结构的具体特征以及特定建模方法最容易表示的问题特征有关的最佳实践。每个部分都包含一些建议,这些建议是在作者、国际药物经济学和结果研究学会以及医学决策学会共同设立的更广泛的建模工作组之间反复提出的。

相似文献

1
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.概念化模型:ISPOR-SMDM 建模良好研究实践工作组 2 的报告。
Med Decis Making. 2012 Sep-Oct;32(5):678-89. doi: 10.1177/0272989X12454941.
2
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.概念化模型:ISPOR-SMDM 建模良好研究实践工作组的报告--2.
Value Health. 2012 Sep-Oct;15(6):804-11. doi: 10.1016/j.jval.2012.06.016.
3
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.模型透明度和验证:ISPOR-SMDM 建模良好实践工作组的报告——7.
Value Health. 2012 Sep-Oct;15(6):843-50. doi: 10.1016/j.jval.2012.04.012.
4
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.建立良好研究实践模型——概述:ISPOR-SMDM 建立良好研究实践工作组 1 的报告。
Med Decis Making. 2012 Sep-Oct;32(5):667-77. doi: 10.1177/0272989X12454577.
5
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.模型化良好的研究实践概述:ISPOR-SMDM 模型化良好的研究实践工作组的报告——1.
Value Health. 2012 Sep-Oct;15(6):796-803. doi: 10.1016/j.jval.2012.06.012.
6
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4.使用离散事件模拟建模:ISPOR-SMDM 建模良好实践工作组的报告-4。
Med Decis Making. 2012 Sep-Oct;32(5):701-11. doi: 10.1177/0272989X12455462.
7
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.使用离散事件模拟建模:ISPOR-SMDM 建模良好实践工作组的报告--4.
Value Health. 2012 Sep-Oct;15(6):821-7. doi: 10.1016/j.jval.2012.04.013.
8
Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.模型透明度和验证:ISPOR-SMDM 建模良好实践工作组报告-7。
Med Decis Making. 2012 Sep-Oct;32(5):733-43. doi: 10.1177/0272989X12454579.
9
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.模型参数估计和不确定性:ISPOR-SMDM 建模良好实践工作组的报告——6.
Value Health. 2012 Sep-Oct;15(6):835-42. doi: 10.1016/j.jval.2012.04.014.
10
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.

引用本文的文献

1
Simulation Modeling of Oral Cancer Development with Risk Stratification: How Potential Screening Programs Can Be Evaluated.口腔癌发展的风险分层模拟建模:如何评估潜在的筛查项目。
MDM Policy Pract. 2025 Aug 19;10(2):23814683251353226. doi: 10.1177/23814683251353226. eCollection 2025 Jul-Dec.
2
Protocol for the economic evaluation alongside the PARTICIPATE (PArticipatory Research model for medicaTIon adherenCe In People with diAbetes and hyperTEnsion) multicenter cluster randomized trial.与 PARTICIPATE(糖尿病和高血压患者药物依从性的参与式研究模型)多中心整群随机试验同步进行的经济评估方案。
BMJ Open. 2025 Jul 22;15(7):e094185. doi: 10.1136/bmjopen-2024-094185.
3
EpiGeoPop: a tool for developing spatially accurate country-level epidemiological models.
EpiGeoPop:一种用于开发空间精确的国家级流行病学模型的工具。
Sci Rep. 2025 Jul 22;15(1):26663. doi: 10.1038/s41598-025-11999-4.
4
Cost-Effectiveness Analyses of Adolescent- and Young-Adult-Focused HIV Interventions Incorporating HIV Transmission: a Scoping Review of Modeling Methods and Proposed Guidance.纳入HIV传播的针对青少年和青年成人的HIV干预措施的成本效益分析:建模方法的范围审查及拟议指南
Pharmacoecon Open. 2025 May 31. doi: 10.1007/s41669-025-00583-1.
5
Patient-level simulation models in cancer care: a systematic review.癌症护理中患者层面的模拟模型:一项系统综述。
Front Public Health. 2025 May 9;13:1335300. doi: 10.3389/fpubh.2025.1335300. eCollection 2025.
6
Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain.对西班牙老年人群流感疫苗经济评估中不确定性的批判性评估。
BMC Infect Dis. 2025 Feb 1;25(1):152. doi: 10.1186/s12879-025-10442-3.
7
Synthesis estimators for transportability with positivity violations by a continuous covariate.用于处理连续协变量违反正性假设的可移植性的合成估计量。
J R Stat Soc Ser A Stat Soc. 2024 Sep 2;188(1):158-180. doi: 10.1093/jrsssa/qnae084. eCollection 2025 Jan.
8
Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force.卫生技术评估指南制定的良好实践:卫生技术评估国际组织、HTAsiaLink及药物经济学与结果研究国际协会特别工作组的报告
Int J Technol Assess Health Care. 2025 Jan 6;40(1):e74. doi: 10.1017/S0266462324004719.
9
Cost-effectiveness models of non-small cell lung cancer: A systematic literature review.非小细胞肺癌的成本效益模型:一项系统的文献综述。
J Manag Care Spec Pharm. 2025 Jan;31(1):69-81. doi: 10.18553/jmcp.2025.31.1.69.
10
Modeling severe uncontrolled asthma: Transitioning away from health states.重度难治性哮喘建模:从健康状态转变
Contemp Clin Trials Commun. 2024 Nov 7;42:101390. doi: 10.1016/j.conctc.2024.101390. eCollection 2024 Dec.